Key Players
Competitive Landscape
Acoustic push-pulse penetration depth in high-BMI patients and multiparametric steatosis attenuation grading separate dedicated hepatology pioneers from general radiology console makers. Multinational imaging conglomerates bundle 2D shear wave and dispersion software onto flagship radiology carts backed by enterprise PACS contracts. In contrast, dedicated point-of-care hepatology leader Echosens SA anchors outpatient liver clinics and pharmaceutical MASH trials with its standardized FibroScan VCTE and CAP metrics. Configurable clinical ultrasound challengers compete by offering cost-effective cart and endoscopic shear wave packages for regional hospitals. Radiology directors qualify platforms on real-time propagation stability maps and interquartile range consistency alongside phantom cross-calibration.
High technical failure rates when scanning central-obesity MASLD cohorts and the clinical need to stage deep pancreatic or left-lobe hepatic lesions during upper endoscopy are reshaping transducer engineering across ultrasound vendors. Addressing bariatric signal attenuation directly, Mindray Bio-Medical Electronics completed clinical validation in January 2026 for multi-frequency acoustic radiation force elastography across its Resona 7 and Hepatus consoles to stabilize deep-tissue kilopascal readings [20]. At the same time, gastroenterology suites are converging endoscopic sonography with quantitative tissue stiffness mapping, corroborated in October 2025 when FUJIFILM Healthcare Corporation integrated shear wave elastography modules across its ARIETTA endoscopic and transabdominal systems [21]. Offering USD 17,200 to USD 29,500 modular software license upgrades alongside endoscopic and deep-abdominal convex transducers allows manufacturers to monetize installed hospital cart fleets without requiring full console replacements.
Company developments mapped to drivers, trends and opportunities (2026-2036)
| Development | Driver | Trend | Opportunity |
|---|---|---|---|
| May 2026: Canon Medical and Olympus launched the Aplio i800 EUS system in the U.S. | Gastroenterologists need deep pancreatic and left-lobe hepatic stiffness grading during endoscopy. | Endoscopic ultrasound consoles integrate quantitative shear wave and attenuation modules. | Combining EUS with quantitative elastography captures tertiary interventional GI suite upgrades. |
| November 2025: FDA accepted Echosens SA's Letter of Intent for FibroScan DDT qualification. | Pharmaceutical MASH trials require non-invasive surrogate endpoints to replace serial biopsies. | Regulators qualify vibration-controlled transient elastography kilopascal cutoffs for drug trials. | Standardized biomarker status drives recurring device placements across digestive trial sites. |
| February 2025: Koninklijke Philips N.V. released Auto ElastQ automated 2D shear wave software. | High outpatient liver screening volumes strain radiology sonographer examination schedules. | Automated confidence maps select optimal measurement frames and compute IQR ratios. | Software license upgrades on installed EPIQ and Affiniti carts generate high-margin recurring revenue. |
| October 2025: Siemens Healthineers AG enhanced deep abdominal shear wave on ACUSON Sequoia. | Conventional push pulses attenuate rapidly in patients with severe central obesity. | High-power acoustic radiation force architectures extend shear wave tracking to 12 cm depth. | Reliable bariatric penetration reduces non-diagnostic exam rates in Western hepatology clinics. |
Source: Future Market Insights, Shear Wave Elastography Market Report, 2026-2036.
Engineering investment across ultrasound elastography vendors centers on multiparametric liver packages that measure fibrosis stiffness and steatosis attenuation alongside necroinflammatory dispersion in one breath-hold. Suppliers that align kilopascal reporting with international QIBA and WFUMB phantom standards secure preferred placement across hospital networks.
How are key market participants positioned in the shear wave elastography market?
Echosens SA operates as the dedicated global hepatology leader with its standalone and guided FibroScan VCTE ecosystem. Siemens Healthineers and GE HealthCare alongside Koninklijke Philips NV and Canon Medical Systems lead the premium hospital radiology cart segment with multiparametric 2D shear wave suites. Mindray Bio-Medical Electronics and Samsung Medison together with FUJIFILM Healthcare and Esaote SpA provide configurable cart and endoscopic elastography platforms for multi-specialty clinics.
What qualification or purchasing requirements matter most to prospective buyers?
Chief abdominal radiologists mandate verified biopsy-correlated kilopascal accuracy and interquartile range-to-median ratios below 30% across obese patient cohorts. Hepatologists require simultaneous ultrasound attenuation imaging to grade hepatic steatosis alongside fibrosis during a single appointment. Hospital procurement officers evaluate software license upgrade pricing on existing cart fleets and structured DICOM SR reporting into PACS archives.
Which product or application capabilities distinguish the leading companies?
Echosens SA distinguishes its FibroScan portfolio with Controlled Attenuation Parameter and SmartExam guided VCTE probes validated in global MASH drug trials. Siemens Healthineers excels in deep-abdominal DAX transducer penetration up to 40 cm on ACUSON Sequoia consoles. Canon Medical Systems leads in Shear Wave Dispersion slope analysis for hepatic inflammation, while Koninklijke Philips NV differentiates through Auto ElastQ frame selection. GE HealthCare pairs 2D shear wave mapping with Ultrasound-Guided Fat Fraction tools on LOGIQ E10 systems.
How does geographic reach differ among the key market players?
Siemens Healthineers and GE HealthCare alongside Koninklijke Philips NV and Canon Medical Systems maintain direct hospital radiology field-service networks across North American and European medical centers. Echosens SA operates direct hepatology commercial teams in the United States and Western Europe as well as China while partnering with specialty distributors in emerging markets. Mindray Bio-Medical Electronics and FUJIFILM Healthcare hold strong installed bases across East Asia and Europe, while Esaote SpA focuses on European and Latin American outpatient clinics.
Representative Company Overview
| Company | Positioning | Verified Development |
|---|---|---|
| Echosens SA | French non-invasive hepatology pioneer manufacturing FibroScan VCTE and CAP platforms. | Received FDA acceptance for its FibroScan Drug Development Tool Letter of Intent in November 2025 and published Guided VCTE best practices in April 2026. |
| Siemens Healthineers AG | German diagnostic imaging leader offering ACUSON Sequoia deep-abdominal shear wave systems. | Released deep abdominal shear wave elastography enhancements on ACUSON Sequoia platforms in October 2025. |
| GE HealthCare Technologies Inc. | Global medical imaging conglomerate producing LOGIQ E10 2D shear wave and UGFF consoles. | Expanded 2D shear wave and ultrasound-guided fat fraction packages across LOGIQ E10 suites in December 2025. |
| Koninklijke Philips N.V. | Dutch health technology company supplying EPIQ Elite and Affiniti Auto ElastQ ultrasound systems. | Introduced Auto ElastQ automated 2D shear wave quantification software updates in February 2025. |
| Canon Medical Systems Corporation | Japanese diagnostic imaging manufacturer known for Aplio i-series shear wave dispersion. | Secured FDA 510(k) clearance for Aplio i-series innovations in November 2025 and launched Aplio i800 EUS in May 2026. |
| Mindray Bio-Medical Electronics Co., Ltd. | Global medical equipment producer offering Resona 7 and Hepatus elastography systems. | Validated multi-frequency acoustic radiation force elastography on Resona 7 systems in January 2026. |
| Samsung Medison Co., Ltd. | South Korean ultrasound manufacturer supplying RS85 Prestige S-Shearwave Imaging consoles. | Expanded S-Shearwave attenuating and stiffness software deployments across university hospitals in early 2026. |
| FUJIFILM Healthcare Corporation | Japanese medical imaging provider offering ARIETTA transabdominal and endoscopic elastography. | Integrated shear wave elastography modules across ARIETTA endoscopic and abdominal ultrasound systems in October 2025. |
| Esaote S.p.A. | Italian medical imaging specialist producing MyLab X90 QElaXto 2D shear wave platforms. | Expanded QElaXto point and 2D shear wave packages for outpatient hepatology and musculoskeletal clinics in early 2026. |
Research Methodology
The shear wave elastography market assessment was conducted using a combination of primary research, secondary research, and data triangulation across hospital radiology console installations, outpatient hepatology clinic registries, and manufacturer software attachment rates to validate 2026 to 2036 projections.
